Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: Weakness; Cough; Flu like symptoms; Diarrhea; Feeling very dizzy/Dizziness; Cloudy vision; Stomach pain; Fever of 37degree celsius/fever reached to 39.5°C; Severe Headache; Fatigue; Joint pain; Muscle pain; Chills; Swollen in the arm of the injection; Swollen lymph nodes; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ASTHENIA (Weakness), COUGH (Cough), INFLUENZA LIKE ILLNESS (Flu like symptoms), DIARRHOEA (Diarrhea) and DIZZINESS (Feeling very dizzy/Dizziness) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Blood pressure high (The patient has high blood pressure.) since an unknown date, High cholesterol (The patient has high cholesterol.) since an unknown date, Arthrosis (The patient has arthrosis.) since an unknown date and Asthma (The patient has asthma.) since an unknown date. Concurrent medical conditions included Latex allergy and Penicillin allergy. Concomitant products included PANTOPRAZOLE SODIUM SESQUIHYDRATE (ZOTONIX) for Antacid therapy, FISH OIL (OMEGA XL) for Antiinflammatory therapy, APETAMIN [CYPROHEPTADINE HYDROCHLORIDE;DEXPANTHENOL;LYSINE HYDROCHLORIDE;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;THIAMINE HYDROCHLORIDE] for Appetite stimulated, CALCIUM for Arthrosis, FLUTICASONE PROPIONATE (FLOVENT) and MONTELUKAST for Asthma, CANDESARTAN, DILTIAZEM and AMLODIPINE BESILATE, VALSARTAN (DISTAN) for Hypertension, CYANOCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE (NERVITE) and ACETYLSALICYLIC ACID (ECOTRIN) for Pain, MULTIVITAMIN [ASCORBIC ACID;BIOTIN;CALCIUM PANTOTHENATE;CYANOCOBALAMIN;FOLIC ACID;NICOTINIC ACID;PYRIDOXINE HYDROCHLORIDE;RIBOFLAVIN;THIAMINE HYDROCHLORIDE;TOCOPHERYL ACETATE] for Vitamin supplementation, ZINC for Zinc supplementation, DICLOFENAC SODIUM (ANTI-INFLAMMATORY) and Muscle relaxant drugs (MUSCLE RELAXANTS) for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced ASTHENIA (Weakness), COUGH (Cough), INFLUENZA LIKE ILLNESS (Flu like symptoms), DIARRHOEA (Diarrhea), DIZZINESS (Feeling very dizzy/Dizziness), VISION BLURRED (Cloudy vision), ABDOMINAL PAIN UPPER (Stomach pain), PYREXIA (Fever of 37degree celsius/fever reached to 39.5°C), HEADACHE (Severe Headache), FATIGUE (Fatigue), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain), CHILLS (Chills), VACCINATION SITE SWELLING (Swollen in the arm of the injection) and LYMPHADENOPATHY (Swollen lymph nodes). The patient was treated with ACETAMINOPHEN (oral) ongoing since an unknown date for Pyrexia, at an unspecified dose and frequency and DEXTROMETHORPHAN HYDROBROMIDE (COUGH SYRUP DEXTROMETHORPHAN) (oral) ongoing since an unknown date for Cough, at an unspecified dose and frequency. On 25-Jan-2021, PYREXIA (Fever of 37degree celsius/fever reached to 39.5°C) had resolved. At the time of the report, ASTHENIA (Weakness), DIARRHOEA (Diarrhea), DIZZINESS (Feeling very dizzy/Dizziness), VISION BLURRED (Cloudy vision), ABDOMINAL PAIN UPPER (Stomach pain) and FATIGUE (Fatigue) had not resolved and COUGH (Cough), INFLUENZA LIKE ILLNESS (Flu like symptoms), HEADACHE (Severe Headache), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain), CHILLS (Chills), VACCINATION SITE SWELLING (Swollen in the arm of the injection) and LYMPHADENOPATHY (Swollen lymph nodes) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jan-2021, Body temperature: 37 degree Celsius (High) the patient has fever. On 23-Jan-2021, Body temperature: 39.5 degree Celsius (High) the patient has fever..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   NOTE: The units for body temperature are DEGREE CELSIUS.   Most recent FOLLOW-UP information incorporated above includes: On 25-Jan-2021: NNI